Cancer Treatment Centers of America (CTCA) is teaming up with Other healthcare companies to offer a customized technical solution that will enable eviti to access clinical documents in an electronic record. Eviti is supported by NantHealth, which allows for the clinical documentation to be made readily available in the Allscripts Sunrise health record. The trio working together has created a smooth transition using Clinical Pathways program to help inform others of the cancer treatment processes without interrupting the work flow of each physician. The process has become more efficient and highly advanced compared to other solution systems they’ve used in the past. The interface of the clinical system is called NantOS and it has helped to input patient information along with all other information into a database which helps oncologist with the information they need in a quick fashion.
Clinical Pathways is also responsible for treatment options that work to eliminate potential guessing by clinicians that are presented with new data. Clinical Pathways was primarily designed with the patient in mind so they receive the most recent cancer treatments available with the most advanced technology.
The headquarters of Cancer Treatment Centers of America are located in Boca Raton, Florida. They consist of five different hospitals that are nationwide. Their facilities are dedicated to patients who are diagnosed with cancer and are receiving treatments. They provide advancements in genomic testing, cancer treatments, surgery, immunotherapy, radiation and chemotherapy. They work with each patient to enhance their quality of life while they’re fighting the disease both during treatment as well as after treatment. Their hospitals are located in Atlanta, Chicago, Phoenix, Philadelphia and Tulsa where they treat many different patients from all over the world. They are a highly rated hospital that delivers outstanding quality of care and patient satisfaction. For more information on their process and options, visit cancercenter.com.